Literature DB >> 1836471

A comparative study of the promotion of tissue plasminogen activator and pro-urokinase-induced plasminogen activation by fragments D and E-2 of fibrin.

J N Liu1, V Gurewich.   

Abstract

Plasmin generation by equimolar concentrations of tissue plasminogen activator (t-PA), pro-urokinase (pro-UK), and urokinase (UK), and a twofold higher concentration of a plasmin-resistant mutant rpro-UK (Ala-158-pro-UK) was measured on a microtiter plate reader. The promoting effects on this reaction of equimolar concentrations of fibrinogen, soluble fibrin (Desafib), CNBr fragment FCB-2 (an analogue of fragment D), or purified fragment E-2 were compared. Plasmin generation by t-PA was moderately promoted by fibrinogen, substantially promoted by Desafib and FCB-2, but not at all promoted by fragment E-2. By contrast, plasmin generation by pro-UK or by Ala-158-pro-UK was not promoted either by fibrinogen, Desafib, or FCB-2, but was significantly promoted by fragment E-2. Plasmin generation by UK was not significantly promoted by any of the fibrin(ogen) preparations. Treatment of fragment E-2 by carboxypeptidase-B (CPB), eliminated its promotion of pro-UK and Ala-158-pro-UK-induced plasmin generation. Pretreatment of FCB-2 with plasmin slightly potentiated its promotion of t-PA activity. This effect of plasmin pretreatment of FCB-2 was reversed by CPB treatment. Plasmin pretreatment of FCB-2 did not induce any promotion of activity in pro-UK or Ala-158-pro-UK. The findings show that the intrinsic activity of pro-UK and the activity of t-PA are promoted by different regions of the fibrin(ogen) molecule. The latter is stimulated primarily by a determinant in the fragment D region, which is available in intact fibrin. By contrast, plasminogen activation by the intrinsic activity of pro-UK was stimulated exclusively by fragment E-2, which is unavailable in intact fibrin. The findings are believed relevant to fibrinolysis and support the concept that t-PA and pro-UK are complementary, sequential, and synergistic in their actions.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1836471      PMCID: PMC295789          DOI: 10.1172/JCI115528

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  19 in total

1.  Pro-urokinase: a study of its stability in plasma and of a mechanism for its selective fibrinolytic effect.

Authors:  R Pannell; V Gurewich
Journal:  Blood       Date:  1986-05       Impact factor: 22.113

2.  One-chain urokinase-type plasminogen activator from human sarcoma cells is a proenzyme with little or no intrinsic activity.

Authors:  L C Petersen; L R Lund; L S Nielsen; K Danø; L Skriver
Journal:  J Biol Chem       Date:  1988-08-15       Impact factor: 5.157

3.  Purification and characterization of single-chain urokinase-type plasminogen activator from human cell cultures.

Authors:  D C Stump; H R Lijnen; D Collen
Journal:  J Biol Chem       Date:  1986-01-25       Impact factor: 5.157

4.  Complementary modes of action of tissue-type plasminogen activator and pro-urokinase by which their synergistic effect on clot lysis may be explained.

Authors:  R Pannell; J Black; V Gurewich
Journal:  J Clin Invest       Date:  1988-03       Impact factor: 14.808

5.  Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin.

Authors:  M Hoylaerts; D C Rijken; H R Lijnen; D Collen
Journal:  J Biol Chem       Date:  1982-03-25       Impact factor: 5.157

6.  Location of plasminogen-binding sites in human fibrin(ogen).

Authors:  A Váradi; L Patthy
Journal:  Biochemistry       Date:  1983-05-10       Impact factor: 3.162

7.  Activation of plasminogen by single-chain urokinase or by two-chain urokinase--a demonstration that single-chain urokinase has a low catalytic activity (pro-urokinase).

Authors:  R Pannell; V Gurewich
Journal:  Blood       Date:  1987-01       Impact factor: 22.113

8.  Beta(Leu121-Lys122) segment of fibrinogen is in a region essential for plasminogen binding by fibrin fragment E.

Authors:  A Váradi; L Patthy
Journal:  Biochemistry       Date:  1984-04-24       Impact factor: 3.162

9.  Characterization of the intrinsic fibrinolytic properties of pro-urokinase through a study of plasmin-resistant mutant forms produced by site-specific mutagenesis of lysine(158).

Authors:  V Gurewich; R Pannell; R J Broeze; J Mao
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

10.  Structure of fragment E species from human cross-linked fibrin.

Authors:  S A Olexa; A Z Budzynski; R F Doolittle; B A Cottrell; T C Greene
Journal:  Biochemistry       Date:  1981-10-13       Impact factor: 3.162

View more
  9 in total

1.  Neutrophil α-defensins promote thrombosis in vivo by altering fibrin formation, structure, and stability.

Authors:  Rami Abu-Fanne; Victoria Stepanova; Rustem I Litvinov; Suhair Abdeen; Khalil Bdeir; Mohamed Higazi; Emad Maraga; Chandrasekaran Nagaswami; Alexander R Mukhitov; John W Weisel; Douglas B Cines; Abd Al-Roof Higazi
Journal:  Blood       Date:  2018-11-15       Impact factor: 22.113

2.  Fibrin-specific and effective clot lysis requires both plasminogen activators and for them to be in a sequential rather than simultaneous combination.

Authors:  R Pannell; S Li; V Gurewich
Journal:  J Thromb Thrombolysis       Date:  2017-08       Impact factor: 2.300

3.  Endogenous plasminogen activators mediate progressive intracerebral hemorrhage after traumatic brain injury in mice.

Authors:  Nuha Hijazi; Rami Abu Fanne; Rinat Abramovitch; Serge Yarovoi; Muhamed Higazi; Suhair Abdeen; Maamon Basheer; Emad Maraga; Douglas B Cines; Abd Al-Roof Higazi
Journal:  Blood       Date:  2015-02-11       Impact factor: 22.113

4.  Extracellular proteolysis of reelin by tissue plasminogen activator following synaptic potentiation.

Authors:  J H Trotter; A L Lussier; K E Psilos; H L Mahoney; A E Sponaugle; H-S Hoe; G W Rebeck; E J Weeber
Journal:  Neuroscience       Date:  2014-06-02       Impact factor: 3.590

5.  Fibrinogen degradation product fragment D induces endothelial cell detachment by activation of cell-mediated fibrinolysis.

Authors:  M Ge; G Tang; T J Ryan; A B Malik
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

6.  Redistribution of TPA Fluxes in the Presence of PAI-1 Regulates Spatial Thrombolysis.

Authors:  Alexey M Shibeko; Bastien Chopard; Alfons G Hoekstra; Mikhail A Panteleev
Journal:  Biophys J       Date:  2020-06-26       Impact factor: 4.033

7.  Highly effective fibrinolysis by a sequential synergistic combination of mini-dose tPA plus low-dose mutant proUK.

Authors:  Ralph Pannell; Shelley Li; Victor Gurewich
Journal:  PLoS One       Date:  2015-03-26       Impact factor: 3.240

Review 8.  Why so little progress in therapeutic thrombolysis? The current state of the art and prospects for improvement.

Authors:  Victor Gurewich
Journal:  J Thromb Thrombolysis       Date:  2015-11       Impact factor: 2.300

9.  Co-ordinated spatial propagation of blood plasma clotting and fibrinolytic fronts.

Authors:  Ansar S Zhalyalov; Mikhail A Panteleev; Marina A Gracheva; Fazoil I Ataullakhanov; Alexey M Shibeko
Journal:  PLoS One       Date:  2017-07-07       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.